Literature DB >> 24736889

A graphical method to compare the in vivo binding potential of PET radioligands in the absence of a reference region: application to [¹¹C]PBR28 and [¹⁸F]PBR111 for TSPO imaging.

Qi Guo1, David R Owen2, Eugenii A Rabiner3, Federico E Turkheimer4, Roger N Gunn5.   

Abstract

Positron emission tomography (PET) radioligands for a reversible central nervous system (CNS) demand a high specific to nonspecific signal characterized by the binding potential (BPND). The quantification of BPND requires the determination of the nondisplaceable binding usually derived from a reference region devoid of the target of interest. However, for many CNS targets, there is no valid reference region available. In such cases, the total volume of distribution (VT) is often used as the outcome measure, which includes both the specific and nonspecific binding signals. Here we present a graphical method that allows for direct comparison of the binding potential of ligands using the regional VT data alone via linear regression. The method was first validated using literature data for five serotonin transporter ligands, for which a reference region exists, and then applied to two second generation 18 kDa translocator protein radioligands, namely [(11)C]PBR28 and [(18)F]PBR111. The analysis determined that [(11)C]PBR28 had a higher BPND than [(18)F]PBR111.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24736889      PMCID: PMC4083379          DOI: 10.1038/jcbfm.2014.65

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  29 in total

1.  Estimation of kinetic parameters in graphical analysis of PET imaging data.

Authors:  R Todd Ogden
Journal:  Stat Med       Date:  2003-11-30       Impact factor: 2.373

Review 2.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

3.  Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle.

Authors:  N A Lassen; P A Bartenstein; A A Lammertsma; M C Prevett; D R Turton; S K Luthra; S Osman; P M Bloomfield; T Jones; P N Patsalos
Journal:  J Cereb Blood Flow Metab       Date:  1995-01       Impact factor: 6.200

4.  Non-linear regression techniques in data analysis.

Authors:  V J Cunningham
Journal:  Med Inform (Lond)       Date:  1985 Apr-Jun

5.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

6.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

7.  Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.

Authors:  Peter S Talbot; W Gordon Frankle; Dah-Ren Hwang; Yiyun Huang; Raymond F Suckow; Mark Slifstein; Anissa Abi-Dargham; Marc Laruelle
Journal:  Synapse       Date:  2005-03-01       Impact factor: 2.562

8.  Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation.

Authors:  Amira K Brown; Masahiro Fujita; Yota Fujimura; Jeih-San Liow; Michael Stabin; Yong H Ryu; Masao Imaizumi; Jinsoo Hong; Victor W Pike; Robert B Innis
Journal:  J Nucl Med       Date:  2007-11-15       Impact factor: 10.057

9.  Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation.

Authors:  Masahiro Fujita; Masao Imaizumi; Sami S Zoghbi; Yota Fujimura; Amanda G Farris; Tetsuya Suhara; Jinsoo Hong; Victor W Pike; Robert B Innis
Journal:  Neuroimage       Date:  2007-11-22       Impact factor: 6.556

10.  Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography.

Authors:  Christopher J R Fookes; Tien Q Pham; Filomena Mattner; Ivan Greguric; Christian Loc'h; Xiang Liu; Paula Berghofer; Rachael Shepherd; Marie-Claude Gregoire; Andrew Katsifis
Journal:  J Med Chem       Date:  2008-06-17       Impact factor: 7.446

View more
  17 in total

1.  In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [11C]ABP688 and [18F]FPEB.

Authors:  Christine DeLorenzo; Jean-Dominique Gallezot; John Gardus; Jie Yang; Beata Planeta; Nabeel Nabulsi; R Todd Ogden; David C Labaree; Yiyun H Huang; J John Mann; Fabrizio Gasparini; Xin Lin; Jonathan A Javitch; Ramin V Parsey; Richard E Carson; Irina Esterlis
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  Parametric mapping using spectral analysis for 11C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects.

Authors:  Zhen Fan; Melanie Dani; Grazia D Femminella; Melanie Wood; Valeria Calsolaro; Mattia Veronese; Federico Turkheimer; Steve Gentleman; David J Brooks; Rainer Hinz; Paul Edison
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-09       Impact factor: 9.236

3.  Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.

Authors:  Sujata Sridharan; Joel Raffel; Ashwini Nandoskar; Chris Record; David J Brooks; David Owen; David Sharp; Paolo A Muraro; Roger Gunn; Richard Nicholas
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

4.  PET imaging of α7 nicotinic acetylcholine receptors: a comparative study of [18F]ASEM and [18F]DBT-10 in nonhuman primates, and further evaluation of [18F]ASEM in humans.

Authors:  Ansel T Hillmer; Songye Li; Ming-Qiang Zheng; Matthias Scheunemann; Shu-Fei Lin; Nabeel Nabulsi; Daniel Holden; Richard Pracitto; David Labaree; Jim Ropchan; Rodrigo Teodoro; Winnie Deuther-Conrad; Irina Esterlis; Kelly P Cosgrove; Peter Brust; Richard E Carson; Yiyun Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-24       Impact factor: 9.236

5.  Design, Synthesis, and Characterization of [18F]mG2P026 as a High-Contrast PET Imaging Ligand for Metabotropic Glutamate Receptor 2.

Authors:  Gengyang Yuan; Maeva Dhaynaut; Nicolas J Guehl; Sepideh Afshar; Dalena Huynh; Sung-Hyun Moon; Suhasini M Iyengar; Manish Kumar Jain; Julie E Pickett; Hye Jin Kang; Mary Jo Ondrechen; Georges El Fakhri; Marc D Normandin; Anna-Liisa Brownell
Journal:  J Med Chem       Date:  2022-07-08       Impact factor: 8.039

6.  Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis.

Authors:  Gourab Datta; Ines R Violante; Gregory Scott; Karl Zimmerman; Andre Santos-Ribeiro; Eugenii A Rabiner; Roger N Gunn; Omar Malik; Olga Ciccarelli; Richard Nicholas; Paul M Matthews
Journal:  Mult Scler       Date:  2016-12-07       Impact factor: 6.312

7.  Measuring specific receptor binding of a PET radioligand in human brain without pharmacological blockade: The genomic plot.

Authors:  Mattia Veronese; Paolo Zanotti-Fregonara; Gaia Rizzo; Alessandra Bertoldo; Robert B Innis; Federico E Turkheimer
Journal:  Neuroimage       Date:  2016-02-02       Impact factor: 6.556

8.  Radiochemical Synthesis and Evaluation in Non-Human Primates of 3-[11C]methoxy-4-aminopyridine: A Novel PET Tracer for Imaging Potassium Channels in the CNS.

Authors:  Nicolas J Guehl; Ramesh Neelamegam; Yu-Peng Zhou; Sung-Hyun Moon; Maeva Dhaynaut; Georges El Fakhri; Marc D Normandin; Pedro Brugarolas
Journal:  ACS Chem Neurosci       Date:  2021-02-04       Impact factor: 4.418

9.  Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates.

Authors:  Olivier Barret; Lei Zhang; David Alagille; Cristian C Constantinescu; Christine Sandiego; Caroline Papin; Jenna M Sullivan; Thomas Morley; Vincent M Carroll; John Seibyl; Jianqing Chen; Chewah Lee; Anabella Villalobos; David Gray; Timothy J McCarthy; Gilles Tamagnan
Journal:  J Nucl Med       Date:  2021-02-12       Impact factor: 10.057

10.  Kinetic Modeling and Test-Retest Reproducibility of 11C-EKAP and 11C-FEKAP, Novel Agonist Radiotracers for PET Imaging of the κ-Opioid Receptor in Humans.

Authors:  Mika Naganawa; Songye Li; Nabeel Nabulsi; Shu-Fei Lin; David Labaree; Jim Ropchan; Hong Gao; Michael Mei; Shannan Henry; David Matuskey; Richard E Carson; Yiyun Huang
Journal:  J Nucl Med       Date:  2020-03-13       Impact factor: 11.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.